94.5 mg
Trade Name
Oxlumo
Solution for injection
Request Type
New Registration
Drug Type
New Drug
Approval Date
SFDA Approved Use
lumasiran is indicated for the treatment of primary hyperoxaluria type 1 (PH1) in all age groups.